🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Carboplatin kills cancer cells mainly through induction of DNA damage (drug...
Status
Terminated
Location
University of California Los Angeles
Start Date
2010-12
Trial ID
NCT01261299
Treatments Being Tested
This is a global, multicenter, randomized, open-label, Phase 2/3 study of D...
Status
Recruiting
Location
Research Site
Start Date
2025-09-26
Trial ID
NCT07129993
Treatments Being Tested
GSK3359609 is an anti-Inducible T cell Co-Stimulator (ICOS) receptor agonis...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-06-23
Trial ID
NCT02723955
This study consists of two parts. Part 1 is a dose-escalation/safety evalua...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2017-05-12
Trial ID
NCT03134638
Quisinostat besides its own efficacy, which can potentially lead to better ...
Status
Completed
Location
Russian Oncological Research Center n.a. N. N. Blokhin RAMS
Start Date
2013-08
Trial ID
NCT02728492
Treatments Being Tested
This study will evaluate the bioavailability between the veliparib tablet f...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-11-15
Trial ID
NCT03400306
Treatments Being Tested
This is a phase Ib single arm, open-label, multiple dose, dose escalating, ...
Status
Completed
Location
Oncology Institute of Southern Switzerland (IOSI)
Start Date
2014-04
Trial ID
NCT02069158
Treatments Being Tested
The purpose of this study is to determine safety and preliminary efficacy o...
Status
Recruiting
Location
University of California at San Diego Moores Cancer Center
Start Date
2024-04-22
Trial ID
NCT06385080
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Herbert Irving Comprehensive Cancer Center
Start Date
1996-05
Trial ID
NCT00008203
The aim of this study is to evaluate the efficacy and safety of TQB2102 com...
Status
Not Yet Recruiting
Location
Henan cancer hospital
Start Date
2025-09-01
Trial ID
NCT07136974
Treatments Being Tested